1st Quarter - Amendment

SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC

Firm
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 21, 2014 $350,000 Replaced
1st Quarter - Amendment (this page) Oct 29, 2014 $360,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

orphan drug tax credt; issues surrounding ADHD, including economic and social impact; binge eating disorder; drug shortages;DEA processes; FDA funding and sequester; specialty tiers; track and trace; bundling rules for the Hospital Outpatient Prospective Payment System; compassionate use; step therapy; line extension rebates

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —
JOHN EDWARD GREISSING New Legal Fellow, Counsel, S. Committee on Judiciary
MARK LENKER —

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.